Mahmoud Salama

ORCID: 0000-0002-0282-8018
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Biology and Fertility
  • Reproductive Health and Technologies
  • Ovarian function and disorders
  • Renal and related cancers
  • Cancer Risks and Factors
  • Assisted Reproductive Technology and Twin Pregnancy
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pluripotent Stem Cells Research
  • Tissue Engineering and Regenerative Medicine
  • Nerve Injury and Rehabilitation
  • BRCA gene mutations in cancer
  • Peripheral Nerve Disorders
  • Ovarian cancer diagnosis and treatment
  • Nerve injury and regeneration
  • Cancer Research and Treatments
  • Colorectal Cancer Surgical Treatments
  • Surgical site infection prevention
  • Acute Lymphoblastic Leukemia research
  • Hernia repair and management
  • Orthopedic Surgery and Rehabilitation
  • 3D Printing in Biomedical Research
  • Birth, Development, and Health
  • Demographic Trends and Gender Preferences
  • Pelvic and Acetabular Injuries
  • Ultrasound and Hyperthermia Applications

Barts Health NHS Trust
2024

Queen Elizabeth Hospital Birmingham
2024

Michigan State University
2021-2024

Manchester Royal Infirmary
2024

Royal London Hospital
2024

Bradford Royal Infirmary
2024

University Hospitals Birmingham NHS Foundation Trust
2024

Royal Derby Hospital
2024

National Health Service
2024

Alexandria University
2021-2024

Fertility preservation (FP) is an important quality of life issue for cancer survivors reproductive age. Despite the existence broad international guidelines, delivery oncofertility care, particularly amongst paediatric, adolescent and young adult patients, remains a challenge healthcare professionals (HCPs). The care variable uptake utilization FP low. Available guidelines fall short in providing adequate detail on how models (MOC) allow real-world application by HCPs.

10.1093/humupd/dmy038 article EN cc-by-nc Human Reproduction Update 2018-10-25
Matteo Lambertini Eva Blondeaux Elisa Agostinetto Anne-Sophie Hamy Hee Jeong Kim and 95 more Antonio Di Meglio Rinat Bernstein‐Molho Florentine Hilbers Katarzyna Pogoda Estela Carrasco Kevin Punie Jyoti Bajpai Michail Ignatiadis Halle C. F. Moore Kelly‐Anne Phillips Angela Toss Christine Rousset‐Jablonski Fedro A. Peccatori Tiphaine Renaud Alberta Ferrari Shani Paluch‐Shimon Robert Fruscio Wanda Cui Stephanie M. Wong Claudio Vernieri Kathryn J. Ruddy Maria Vittoria Dieci Alexios Matikas Mariya Rozenblit Cynthia Villarreal‐Garza Laura De Marchis Lucia Del Mastro Fabio Puglisi Maria Del Pilar Estevez Diz Kenny A. Rodriguez‐Wallberg Bela Mriňáková Sarah Meister Luca Livraghi Florian Clatot Rinat Yerushalmi Carmine De Angelis Rodrigo Sánchez-Bayona Icro Meattini Natalia Cichowska-Cwalińska Martine Berlière Mahmoud Salama Ugo De Giorgi Amir Sonnenblick Camila Chiodi Young‐Jin Lee Camille Maria Hatem A. Azim Luca Boni Ann H. Partridge Evandro de Azambuja Chiara Molinelli Marianne Paesmans Lieveke Ameye Frédéric Amant Hilde Brems Sileny Han Sigrid Hatse Ines Nevelsteen Patrick Neven Ann Smeets Chantal Van Rompuy Hans Wildiers François Duhoux Federica Giugliano Carmen Criscitiello Roberto Borea Luca Arecco Alessandra Chirco Federica Bini Marta Venturelli Laura Cortesi Riccardo Ponzone Nicoletta Tomasi Cont Judith Balmañà Rossella Graffeo Helena Luna Pais Alejandro Mohar Tamara Palacios Lucia Da Ros Gianmaria Miolo Mattia Garutti Brenno Pastò Simon Spazzapan Alessandra Viel José Alejandro Pérez Fidalgo Renata Colombo Bonadio Tamar Peretz‐Yablonski Chiara Annunziata Pasqualina Anghelone Angelica Della Valle Maria Campanella Valentina Guarneri Raphaëlle Bas Pierre-Étienne Heudel Olivier Trédan Solenne de Talouet

Importance Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy survivors included limited data BRCA carriers. Objective To investigate cumulative incidence disease-free survival young are Design, Setting, Participants International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The...

10.1001/jama.2023.25463 article EN JAMA 2023-12-07

Abstract Background The incidence of cancer diagnosed during pregnancy is increasing. Data relating to investigation and management, as well maternal foetal outcomes lacking in a United Kingdom (UK) population. Methods In this retrospective study we report data from 119 patients with 14 centres the UK across five-year period (2016-2020). Results Median age at diagnosis was 33 years, breast, skin haematological most common primary sites. majority cases were new diagnoses (109 patients,...

10.1038/s41416-024-02605-x article EN cc-by British Journal of Cancer 2024-02-21

Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed meet patient demand often are fragmented along disciplinary lines. We quantify assets gaps in oncofertility care a global scale.Survey-based questionnaires were provided 191 members of the Consortium Global Partners Network, National Institutes Health-funded organization. Responses analyzed measure trends regional subtleties...

10.1200/jgo.2016.008144 article EN cc-by-nc-nd JCO Global Oncology 2017-06-28
Teresa K. Woodruff Lauren Ataman Kelly S. Acharya Teresa Almeida‐Santos Antoinette Anazodo and 95 more Richard A. Anderson Leslie Appiah Joy Bader Kerri Becktell Robert E. Brannigan Lesley Breech María T. Bourlon Žana Bumbulienė Karen Burns Lisa Campo‐Engelstein Jacira Ribeiro Campos Grace M. Centola Maurício B. Chehin Diane Chen Michel De Vos Francesca E. Duncan Ahmed El‐Damen Douglas Fair Yemi Famuyiwa Patricia Y. Fechner Paula Fontoura Olivia Frias Sabrina A. Gerkowicz Jill P. Ginsberg Clarisa R. Gracia Kara N. Goldman Veronica Gomez‐Lobo Brent Hazelrigg Michael H. Hsieh Luis R. Hoyos Alfonso Hoyos-Martínez Robert Jach Jacek Jassem Murid Javed Yasmin Jayasinghe Roohi Jeelani Jacqueline S. Jeruss Nalini Kaul-Mahajan Jessica Keim‐Malpass Tyler G. Ketterl Mohamed Khrouf Dana Kimelman Atsuko Kusuhara William H. Kutteh Monica M. Laronda Jung Ryeol Lee Vicky Lehmann Joseph M. Letourneau Lynda K. McGinnis Eileen McMahon Lillian R. Meacham Monserrat Fabiola Velez Mijangos Molly B. Moravek Leena Nahata George Moses Ogweno Kyle E. Orwig Mary Ellen Pavone Fedro A. Peccatori Romina Pesce Hanna Pulaski Gwendolyn P. Quinn R. Quintana Tomas Quintana Bruno Ramalho de Carvalho Rosalind Ramsey‐Goldman Joyce Reinecke Fernando M. Reis Julie Sroga Rios Alice Rhoton-Vlasak Kenny A. Rodriguez‐Wallberg Cassandra Roeca Seth J. Rotz Erin E. Rowell Mahmoud Salama Amanda Saraf Aníbal Scarella Tara Schafer-Kalkhoff Deb Schmidt Suneeta Senapati Divya Shah Ariella Shikanov Margarett Shnorhavorian Jodi Skiles James F. Smith Kristin Smith Fabio Sobral Kyle Stimpert H. Irene Su Kouhei Sugimoto Nao Suzuki Mili Thakur David Victorson Luz Viale Wendy Vitek William H. Wallace

10.1007/s10815-020-01983-4 article EN Journal of Assisted Reproduction and Genetics 2021-01-01

Despite international evidence about fertility preservation (FP), several barriers still prevent the implementation of equitable FP practice. Currently, oncofertility competencies do not exist. The aim this study was to develop an competency framework that defines key components care, develops a model for prioritizing service development, and roles health care professionals (HCPs) play.A quantitative modified Delphi methodology used conduct two rounds electronic survey, querying synthesizing...

10.1634/theoncologist.2019-0043 article EN The Oncologist 2019-05-30

Purpose In the accompanying article, “Survey of Fertility Preservation Options Available to Patients With Cancer Around Globe,” we showed that specific fertility preservation services may not be offered at various sites around world because cultural and legal barriers. We assessed global regional experiences as well status third-party reproduction adoption serve a comprehensive international data set resource for groups wish begin oncofertility interventions. Methods provide on legalities...

10.1200/jgo.2017.009944 article EN cc-by-nc-nd JCO Global Oncology 2017-06-30

Phosphatidylserine is the phospholipid component which plays a key role in cell cycle signaling, specifically regards to necrosis and apoptosis. When affected by some negative factors, phosphatidylserine no longer restricted intracellular side of membrane can be translocated extracellular surface cell. Cryopreservation induce translocation response hypoxia, increasing Ca2+, osmotic disruption cellular membranes, generation reactive oxygen species lipid peroxidation. As such aim this study...

10.1186/s12958-016-0213-6 article EN cc-by Reproductive Biology and Endocrinology 2016-11-10

Oncofertility is an emerging discipline which aims to preserve fertility of young cancer patients. As preservation services have become increasingly available patients in many countries around the globe, it crucial establish a foundation collaborative reporting continuously monitor and assess oncofertility practices. This survey study investigates current global landscape official national registries, vital tool allows for surveillance field.

10.3389/fendo.2023.1148314 article EN cc-by Frontiers in Endocrinology 2023-05-08

It is not uncommon for a severe traumatic brachial plexus injury to involve all 5 roots, resulting in flail upper limb. In such cases, surgical reconstruction often palliative, providing only rudimentary function. Nerve transfers are the mainstay of reconstructive strategies due predominance root avulsions. Consistent results obtained restoration shoulder stability and elbow flexion, whereas restoring useful hand function remains challenge. The transfer contralateral C-7 (cC-7) commonly used...

10.3171/2017.4.focus1794 article EN Neurosurgical FOCUS 2017-07-01

The state of limited resource settings that Coronavirus (COVID-19) pandemic has created globally should be taken seriously into account especially in healthcare sector. In oncofertility, patients receive their fertility preservation treatments urgently even before initiation anticancer therapy. Therefore, it is very crucial to learn more about oncofertility practice such as developing countries suffer often from shortage services provided young with cancer. As an extrapolation during the...

10.1007/s10815-020-01821-7 article EN other-oa Journal of Assisted Reproduction and Genetics 2020-06-27

Little is known about oncofertility practice in developing countries that usually suffer from a shortage of health services, especially those related to cancer care.

10.1200/jgo.17.00121 article EN cc-by-nc-nd Journal of Global Oncology 2018-02-07
Coming Soon ...